Drug intelligence / Profile preview

Newxxitek HVT + ND

Development stage
Unknown
Lead developer
Boehringer Ingelheim
Modality
Vaccines & Immunotherapeutics
Administration
In Ovo, Subcutaneous
01

Overview

Newxxitek HVT + ND is a **live vectored veterinary vaccine** for chickens developed by **Boehringer Ingelheim** to help prevent **Marek's disease** and **Newcastle disease**. The product uses **serotype 3 Marek's disease virus**, also known as **herpesvirus of turkeys**, as a viral vector carrying a genetic insert encoding the **Newcastle disease virus fusion protein**. After hatchery administration to either **18 to 19 day-old embryonated eggs** or **day-old chicks**, the vaccine is intended to induce protective immunity against both pathogens in broilers, replacement pullets, and breeder birds. It is a **frozen liquid nitrogen biologic** used in poultry production and was reported as launched in 2018 in velogenic Newcastle disease areas including Peru, Egypt, the Philippines, and Thailand.

Brand names
Newxxitek HVT + NDNewxxitek HVT+ND
Other names
Newxxitek HVT + NDNewxxitek HVT+ND
02

Targets

HMPV F (Human metapneumovirus fusion protein)

Beyond the preview

Go deeper on Newxxitek HVT + ND.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Newxxitek HVT + ND.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call